- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2020-05-01 18:00:12
- Reporting Period:
- Accepted Time:
- 2020-05-01 18:00:12
- SEC Url:
- Form 4 Filing
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|1070494||Acadia Pharmaceuticals Inc||ACAD||Pharmaceutical Preparations (2834)||061376651|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1772518||Elena Ridloff||C/o Acadia Pharmaceuticals Inc. |
3611 Valley Centre Drive, Suite 300
San Diego CA 92130
|Evp And Cfo||No||Yes||No||No|
Reported Non-Derivative Transactions
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
Reported Derivative Transactions
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Common Stock||Stock Option (Right to Buy)||Disposition||2020-04-29||10,000||$0.00||10,000||$25.12|
|Common Stock||Restricted Stock Units||Disposition||2020-04-29||3,245||$0.00||3,245||$0.00|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2019.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.50 to $51.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
- The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- 25% of the 45,547 shares originally subject to the stock option vested and became exercisable on April 29, 2020, and the remaining shares vest in 36 equal monthly installments thereafter.
- The restricted stock units vest in four equal annual installments beginning 4/29/2020.